CommercialCoverageMedium impact
05.00.73g, Neuromuscular Electrical Stimulators (NMES) and Functional Electrical Stimulators (FES)
Independence Blue Cross·Physical Therapy, Occupational Therapy, Pain Management +2 more·Medical Policy
Effective date
May 28, 2025
We identified it
Jun 19, 2026
Summary
Policy 05.00.73g regarding Neuromuscular Electrical Stimulators (NMES) and Functional Electrical Stimulators (FES) has been reissued effective 05/28/2025. This is a recent policy update that supersedes prior guidance on electrical stimulation devices. The billing team must review the full policy text to identify specific coverage criteria, prior authorization requirements, and billing code updates for NMES and FES devices.
Action Required
By 05/28/2025: Billing team must obtain and review the complete policy text at https://medpolicy.ibx.com/ibc/Commercial/Pages/Site-Activity-View.aspx?FilterField1=MPSiteActivityLogMonth&FilterValue1=05&FilterField2=MPSiteActivityLogYear&FilterValue2=2025#commercial-05-00-73g to identify: (1) specific CPT/HCPCS codes affected, (2) prior authorization requirements, (3) medical necessity criteria, and (4) any documentation requirements. Update billing software and provider encounter templates accordingly. Identify all claims for NMES and FES devices currently in process and ensure compliance with new requirements. Train billing and clinical staff on policy changes. Contact the payer if specific billing codes or prior auth triggers are unclear.